Short answer
ApoB and Lp(a) are advanced blood tests related to cholesterol and cardiovascular risk. ApoB estimates the number of artery-plaque-forming lipoprotein particles, while Lp(a) measures a mostly inherited LDL-like particle that can increase heart disease and stroke risk. They are not replacements for a standard lipid panel, but they can add useful risk context for some people.
What the tests measure
| Test | Plain-English meaning | Why it can matter |
|---|---|---|
| ApoB | A protein found on many cholesterol-carrying particles that can contribute to artery plaque. | ApoB can reflect the number of atherogenic particles, which may add context when LDL cholesterol alone underestimates risk. |
| Lp(a) | Lipoprotein(a), an LDL-like particle with an added inherited protein component. | High Lp(a) may increase risk for heart disease and stroke even when standard cholesterol results do not look alarming. |
| Standard lipid panel | Total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. | Still the usual starting point for cholesterol screening and risk discussion. |
How ApoB differs from LDL cholesterol
LDL cholesterol reports how much cholesterol is carried inside LDL particles. ApoB is different: it helps estimate how many potentially plaque-forming particles are circulating. The American Heart Association says ApoB may be useful when someone has high triglycerides, metabolic syndrome, type 2 diabetes, cardio-kidney-metabolic syndrome, HIV infection, or cancer-related risk context, because standard cholesterol results may not capture residual particle-related risk.
How Lp(a) differs from LDL cholesterol
MedlinePlus describes Lp(a) as a type of LDL. Unlike many cholesterol markers, Lp(a) is largely inherited. MedlinePlus says the test is not a routine screening test and is often ordered when a clinician thinks a person may be at high cardiovascular risk or when high Lp(a) runs in the family. The American Heart Association says a standard lipid panel does not include Lp(a), and newer AHA/ACC guidance recommends that adults have Lp(a) tested at least once in their lifetime.
When testing may be discussed
- Family history of early heart attack, stroke, or blood vessel disease.
- Heart or blood vessel disease despite ordinary lipid numbers.
- High LDL cholesterol despite treatment.
- High triglycerides, metabolic syndrome, type 2 diabetes, or other situations where ApoB may clarify particle-related risk.
- Interest in inherited risk after a standard cholesterol discussion.
Result caveats
Do not treat ApoB or Lp(a) as standalone verdicts. Cardiovascular risk also depends on age, blood pressure, diabetes, smoking, kidney disease, family history, pregnancy-related history, inflammatory conditions, medications, and other context. Lp(a) results can be reported in different units, commonly nmol/L or mg/dL, and those units are not simply interchangeable.
Questions to ask
- Was this ordered to clarify inherited risk, residual risk, or a mismatch in my lipid panel?
- What unit is my Lp(a) result reported in?
- How do ApoB, LDL cholesterol, non-HDL cholesterol, triglycerides, and family history fit together?
- If Lp(a) is high, which modifiable risk factors should I focus on most?
- Should relatives consider testing, especially if there is early cardiovascular disease in the family?